IMGN - ImmunoGen Q2 Earnings Preview July, 28 2022 12:42 PM ImmunoGen Inc. ImmunoGen ( NASDAQ: IMGN ) is scheduled to announce Q2 earnings results on Friday, July 29th, before market open. EPS Estimate is -$0.21 (-40.0% Y/Y) and the consensus Revenue Estimate is $16.18M (-4.5% Y/Y). For further details see: ImmunoGen Q2 Earnings Preview